Site Map

Clinical Practice Guidelines

KDIGO Guideline Development Process

KDIGO Guideline for Hepatitis C in CKD
            Translations of Guideline Executive Summary

Participate in the Guideline Review Process

Nephrology Guideline Database
            Guideline Coordination Initiative

Guideline Overviews

Guideline Summaries by Topic

            Compare Guideline Targets

General Nephrology

target hemoglobin
mineral metabolism targets: stage 3
mineral metabolism targets: stage 4
target blood pressure
preferred nephroprotective agents
protocol for hepatitis B vaccination
time referral to the nephrologist
cardiovascular screening in kidney disease

Hemodialysis

target hemoglobin
Kt/V urea
mineral metabolism targets: stage 5
target blood pressure
middle molecule removal
bacteriological dialysate purity
anticoagulation (HD) with bleeding risk
anticoagulation (HD) without bleeding risk
anticoagulation for HIT
time to start dialysis
chemical dialysate purity
preferred vascular access

Vascular Access for HD

preferred vascular access (Rationale)
prevention of infection general
prevention of infection AV-fistulae
prevention of infection AV-graft
prevention of infection central vein catheters
treatment general
treatment AV-fistulae
treatment AV-graft
treatment central vein catheters

Peritoneal Dialysis

target hemoglobin
mineral metabolism targets: stage 5
target blood pressure
time to start dialysis
adequacy of PD
treatment of peritonitis
treatment of exit site infection
prevention of exit site infection and peritonitis

Laboratory Determinations

target lipid concentrations
target CRP
target CO2
target parameters iron reserve
estimation kidney function

Guideline Target Rationales

Meetings & Events

Upcoming KDIGO Presentations

Controversies Conference

Event Photos

Initiatives

Controversies Conference

Evidence Rating Process

Mineral Bone Initiative

Publications

KDIGO Position Statements:

Educational Materials:

Resources

Speaker Center

Home
About Us
Contact Us
Our Supporters